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SUMMARY. Trichomoniasis is the most common, curable sexually transmitted disease in the world. The
first line treatment of trichomoniasis is metronidazole. Recently, the resistance of T. vaginalis to metron-
idazole and imidazoles has been shown to increase. Ivermectin is a synthetic machrolid drug with activity
versus endo and ectoparasitic organisms. In this assay, was tested the effects of ivermectin on T. vaginalis
trophozoites. Ivermectin have anti-parasitic activity upon trichomonas trophozoites. However, the IC50 of
ivermectin against T. vaginalis was high compared with metronidazole.
